US Health Aid Cuts Jeopardize Global HIV, Malaria Fight

Funding cuts and policy changes by the Trump administration are undermining global and US efforts to research, prevent, and treat HIV and malaria. Termination of HIV vaccine studies and significant reductions to the CDC's Ending the HIV Epidemic program threaten progress within the US and abroad. In South Africa, clinical trials and research are at risk due to reliance on US NIH support, while the Democratic Republic of Congo faces reduced malaria prevention capabilities. In the Caribbean, 80% of HIV service organizations report major disruptions from a US funding pause, endangering services for vulnerable communities. Experts warn these actions could reverse years of progress, increase health risks, and trigger layoffs and research site closures worldwide. International organizations and health experts are urging immediate action and alternative funding to sustain critical health services.